Nodule Evaluation
Examination and ultrasound describe the nodule and help determine whether tissue sampling is appropriate.
Thyroid Cancer Pathology Support
Understanding Your Thyroid Cancer Pathology Report
Get a clearer explanation of the diagnosis, Bethesda category, tumor type, size, focality, capsular or vascular invasion, extrathyroidal extension, margins, lymph nodes, and molecular findings documented in your thyroid pathology report.
This educational consultation explains your existing written pathology report. It does not provide a new diagnosis, written report, official document, treatment plan, or replacement for your treating clinicians.
Understand what your report documentsAnd what may still depend on ultrasound, surgery, laboratory tests, molecular studies, or other clinical information.
Board-Certified PathologistProfessional pathology-report guidance
Secure Virtual AppointmentMeet online from the comfort of home
Patient-Friendly ExplanationClear language for complex report findings
Educational SupportNot a replacement for medical advice
Understanding the Process
How a Thyroid Cancer Diagnosis Is Established
A thyroid nodule may be identified by examination or imaging. Fine-needle aspiration can classify sampled cells, while surgical pathology can evaluate the tumor and surrounding thyroid more completely.
Fine-Needle Aspiration
A thin needle collects cells. The cytology report may use a Bethesda category to communicate the result and level of uncertainty.
Surgical Pathology
If thyroid tissue is removed, the pathologist evaluates the tumor type, size, invasion, margins, and other specimen-specific findings.
Wider Clinical Assessment
Ultrasound, laboratory results, cytology or surgical pathology, molecular findings, and health history are considered together by the care team.
A Bethesda category is not a cancer stage. It is a thyroid cytology reporting category. A complete diagnosis may require correlation with molecular testing or examination of surgically removed tissue.
Different Reports, Different Questions
Fine-Needle-Aspiration Versus Thyroidectomy Pathology
FNA evaluates a sample of cells from a nodule. Lobectomy or thyroidectomy allows assessment of tissue architecture, the tumor capsule, blood-vessel invasion, margins, and anatomic extent.
Cytology Sample
Fine-Needle-Aspiration Report
The report describes the sampled cells and usually assigns a Bethesda category.
- Specimen adequacy
- Cytologic description or diagnosis
- Bethesda category
- Selected immunostains or molecular testing
- Recommendations or limitations stated by the laboratory
Surgical Tissue
Lobectomy or Thyroidectomy Report
Removed thyroid tissue can answer additional classification and staging questions.
- Histologic type and tumor size
- Tumor focality and encapsulation
- Capsular, lymphatic, or vascular invasion
- Extrathyroidal extension and margins
- Lymph nodes and pathologic categories when submitted
Inside the Report
What Your Thyroid Cancer Pathology Report May Tell You
The details available depend on whether the specimen is an FNA, core biopsy, lobectomy, thyroidectomy, lymph-node sample, or another submitted tissue.
Read the specimen type before interpreting the result.
An FNA samples cells and cannot answer every question that can be assessed in an excision. For some follicular-patterned tumors, capsular or vascular invasion can only be evaluated in surgically removed tissue.
Diagnosis and Tumor Type
The report may identify papillary, follicular, medullary, poorly differentiated, anaplastic, or another thyroid tumor type when the specimen supports classification.
Bethesda Category
An FNA report may use Bethesda categories I through VI to communicate adequacy and the cytologic interpretation.
Tumor Size and Focality
A surgical report records the largest tumor dimension and whether one or multiple tumor foci are identified.
Capsular and Vascular Invasion
For encapsulated follicular-patterned tumors, the report may document invasion through the capsule or into blood vessels.
Lymphatic Invasion
Tumor within lymphatic spaces may be reported separately from blood-vessel invasion.
Extrathyroidal Extension
A surgical report may describe gross or microscopic extension beyond the thyroid when assessable and relevant to the tumor type.
Surgical Margins
The report states whether tumor reaches an inked specimen edge and may identify the involved margin.
Regional Lymph Nodes
When nodes are submitted, the report may document the number examined and involved, deposit size, and extranodal extension.
Need Help Understanding These Findings?
Review the diagnosis, Bethesda category, specimen limitations, invasion findings, margins, nodes, and pending results in your existing thyroid pathology report during a secure virtual consultation.
Bethesda INondiagnostic or unsatisfactory
Bethesda IIBenign
Bethesda IIIAtypia of undetermined significance
Bethesda IVFollicular neoplasm or suspicious for one
Bethesda V–VISuspicious for malignancy or malignant
Understanding Thyroid Cytology
What the Bethesda Category Communicates
The Bethesda system standardizes thyroid FNA reporting. The category summarizes the cytology interpretation; it does not replace the exact wording, specimen comments, molecular results, or clinical assessment.
The Exact Wording Matters
Each category includes a descriptive diagnosis and may include comments about specimen adequacy, limitations, or next steps.
Indeterminate Does Not Mean Confirmed Cancer
Bethesda III and IV results identify uncertainty in the sampled cells. Molecular testing or surgical pathology may provide additional information.
Surgical Findings Use Different Elements
Once tissue is removed, the report focuses on histologic type, invasion, margins, lymph nodes, and pathologic categories rather than a Bethesda number.
After Thyroid Surgery
Findings That Help Describe Tumor Extent
Surgical pathology may show whether a tumor is limited to the thyroid or involves nearby structures, margins, or lymph nodes. These findings are interpreted with tumor type and wider clinical information.
Tumor Focality
The report may state whether the tumor is unifocal or multifocal and identify the size of the largest focus.
Vascular Invasion
The number and extent of involved blood vessels may matter for selected follicular-derived tumors and are recorded when assessable.
Extrathyroidal Extension
The report documents extension beyond the thyroid according to what is identified in the surgical specimen and operative context.
Surgical Margins
A positive margin means tumor reaches an inked tissue edge; this is separate from whether the tumor extends beyond the thyroid.
Regional Lymph Nodes and Pathologic Categories
When nodes are removed, the report records the number examined and involved and may describe deposit size or extranodal extension. The complete stage also depends on tumor type, age for differentiated thyroid carcinoma, and clinical information.
Additional Testing
Immunohistochemistry, Molecular Testing, and Inherited Risk
Additional tests vary by tumor type and specimen. Results may appear in the main report, an addendum, a separate molecular report, or a genetics document.
Diagnostic Immunohistochemistry
Immunostains may help establish thyroid origin or distinguish among tumor types in selected cases.
IHCTumor type
Tumor Molecular Testing
Selected FNA or tumor specimens may be tested for alterations involving genes such as BRAF, RAS, RET, or NTRK, depending on the clinical question.
DNA / RNASelected genes
Inherited Genetic Testing
Germline testing is separate from tumor testing and may be relevant to hereditary syndromes, particularly in medullary thyroid carcinoma or a suggestive family history.
GermlineGenetic counseling
Tumor molecular testing and inherited genetic testing are not the same. Their meaning depends on the exact test, specimen, tumor type, and clinical context. A consultation explains documented findings without predicting treatment response or recommending therapy.
Questions About a Bethesda Result or Molecular Addendum?
Get a patient-friendly explanation of studies already documented in your reports and identify which results may still be pending or reported separately.
Putting the Results Together
What Is Confirmed, Pending, or Dependent on Other Information?
A thyroid pathology report may answer many important questions, but it does not provide the complete clinical stage or treatment plan on its own.
Confirmed in the Report
Documented Pathology Findings
The diagnosis, Bethesda category or histologic type, tumor size, invasion, margins, nodes, and specimen-specific findings may be documented when assessable.
May Still Be Pending
Addenda or Separate Results
Immunohistochemistry, molecular testing, outside consultation, later surgery, lymph-node findings, or genetic testing may be pending or separately reported.
Requires Wider Context
Clinical Stage and Care Planning
Ultrasound or other imaging, laboratory results, age, health history, operative findings, and evaluation by the treating team provide wider context.
How HONEST Pathology Helps
A Clearer Explanation of the Report You Already Have
A pathology report consultation helps you understand terminology and findings already documented, so you can approach conversations with your treating team with greater context and more focused questions.
Upload Your Reports and Records
Submit the pathology report and relevant records requested for the consultation.
Meet Online With a Pathologist
Discuss the report during a private virtual appointment and ask questions about the documented findings.
Receive a Plain-Language Explanation
Better understand the terminology and prepare questions to discuss with your treating care team.
Consultation Scope
What the Consultation Includes and Excludes
A report explanation and a formal microscopic second opinion are different services. Clear boundaries help you choose the appropriate option.
The Consultation May Explain
- The documented thyroid diagnosis and pathology terminology
- Differences between FNA cytology and surgical pathology
- Bethesda category, specimen adequacy, and stated limitations
- Tumor type, size, focality, and invasion findings
- Extrathyroidal extension, margins, and lymph-node findings
- Immunostains, molecular studies, and pending addenda
- Questions to discuss with your treating team
The Consultation Does Not Include
- A new pathology diagnosis or replacement interpretation
- A new written report or official document
- Clinical staging or risk classification from pathology alone
- Treatment prescribing or replacement of the medical care team
- Physical examination, ultrasound interpretation, or laboratory interpretation in isolation
- Microscopic slide review unless a separate pathology second-opinion service is ordered
Choosing the Right Service
Report Consultation or Formal Pathology Second Opinion?
The right option depends on whether you need help understanding written results or an independent review of pathology slides, tissue, or digital images.
Frequently Asked Questions
Questions About Thyroid Cancer Pathology Reports
These answers provide general educational information. Individual reports vary according to specimen, procedure, tumor type, prior treatment, additional testing, and wider clinical situation.
Does a thyroid nodule mean cancer?
No. Thyroid nodules are common and many are benign. Ultrasound, FNA cytology, and sometimes molecular or surgical pathology help clarify the finding.
What is a Bethesda category?
It is a standardized category used for thyroid FNA cytology. It communicates the interpretation and level of uncertainty but is not a cancer stage.
Why can an FNA be indeterminate?
An FNA shows sampled cells but not the complete relationship between a tumor and its capsule or blood vessels. Some follicular-patterned lesions require surgical tissue for definitive classification.
What is the difference between papillary and follicular thyroid carcinoma?
They are distinct tumor types with different microscopic and molecular features. The exact subtype and specimen findings should be read from the final pathology report.
What does vascular invasion mean?
It means tumor is identified within blood vessels according to pathologic criteria. The report may describe the extent when relevant and assessable.
What does extrathyroidal extension mean?
It describes tumor extending beyond the thyroid into specified surrounding tissues. Its interpretation depends on what was assessable and the exact report wording.
Why might molecular testing be added?
Selected tests may help clarify an indeterminate nodule, classify a tumor, or document alterations relevant to the wider case. Not every patient or specimen needs the same testing.
When is a formal pathology second opinion more appropriate?
A formal second opinion may be appropriate when findings are complex, uncertain, unexpected, or when independent examination of the original slides or tissue could provide additional value.
Clearer Answers Begin Here
Understand the Findings in Your Thyroid Pathology Report
Meet online with a pathologist who can explain the Bethesda category, tumor type, invasion findings, margins, lymph nodes, specimen limitations, molecular studies, and questions raised by your existing report.
Educational support only. This service does not replace your treating physician, endocrinologist, endocrine surgeon, oncologist, radiologist, genetic counselor, or medical care team.
